Back to Search
Start Over
Family Screening in DCM: Can Genetics and Baseline Clinical Data Assist Prognostication and Surveillance Planning?
- Source :
-
JACC. Heart failure [JACC Heart Fail] 2022 Nov; Vol. 10 (11), pp. 804-806. Date of Electronic Publication: 2022 Oct 12. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Funding Support and Author Disclosures Dr Hinson receives consulting fees from Alnylam Pharmaceuticals, Kate Therapeutics, BioMarin Pharmaceutical, and Tevard Biosciences; is a scientific advisory board member of Kate Therapeutics; and also receives sponsored research from Kate Therapeutics and Tevard Biosciences. Dr Wren has reported that she has no relationships relevant to the contents of this paper to disclose.
- Subjects :
- Humans
Pedigree
Mutation
Heart Failure
Cardiomyopathy, Dilated
Subjects
Details
- Language :
- English
- ISSN :
- 2213-1787
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- JACC. Heart failure
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36328646
- Full Text :
- https://doi.org/10.1016/j.jchf.2022.08.003